StockNews.AI
NUWE
StockNews.AI
4 days

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

1. Nuwellis to present at Webull Financial Webinar Series on August 21, 2025. 2. Presentation led by CEO John Erb to discuss fluid management solutions. 3. Nuwellis focuses on the Aquadex SmartFlow® system for critically ill patients. 4. Webinar aligns Nuwellis with innovative investment trends and broader market presence.

4m saved
Insight
Article

FAQ

Why Bullish?

Nuwellis's participation in a strategic webinar can attract investor interest, similar to other biotech firms that saw price increases after investor presentations.

How important is it?

The webinar offers a platform to increase visibility and credibility, crucial for driving investor interest.

Why Short Term?

The upcoming webinar is scheduled shortly, meaning immediate market attention and potential stock movement could occur.

Related Companies

MDGLCRMDHRTS
MINNEAPOLIS, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company delivering fluid management solutions for critically ill patients, today announced that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19-21, 2025. Details for the presentation are as follows: Date/Time: Thursday, August 21, 2025 at 2:40 PM ET Presenter: John Erb, President and Chief Executive OfficerRegistration Link: HERE About Webull Financial Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a wide range of assets, advanced charting tools, and real-time market data, Webull is revolutionizing the way individuals approach investing. The user-centric approach and commitment to staying at the forefront of industry trends underscore the mission to provide a seamless and rewarding experience for traders of all levels. Through the Webull Group, Webull Financial and its affiliates combine to serve tens of millions of users from over 180 countries worldwide. Securities and futures trading is offered to customers by Webull Financial LLC ("Webull Financial"), a broker-dealer registered with the Securities and Exchange Commission (SEC) and a futures commission merchant registered with the Commodity Futures Trading Commission (CFTC). Webull Financial is a member of the Financial Industry Authority (FINRA), the National Futures Association (NFA), and the Securities Investor Protection Corporation (SIPC). All investing is subject to risk, including the possible loss of principal. For more information about Webull, visit www.webull.com. About Nuwellis Nuwellis, Inc. (Nasdaq: NUWE) is a medical device company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovation. The company is focused on commercializing the Aquadex SmartFlow® system for ultrafiltration therapy. Nuwellis is headquartered in Minneapolis, with a wholly owned subsidiary in Ireland. For more information visit www.nuwellis.com or visit us on LinkedIn or X, formerly known as Twitter. For further information, please contact: Investor Contact:JTC Team, LLCJenene Thomas(908) 824-0775nuwe@jtcir.com Media Contact: Leah McMullenDirector of CommunicationsLeah.mcmullen@nuwellis.com

Related News